AVITA Medical (RCEL) Return on Capital Employed (2020 - 2026)
AVITA Medical's (RCEL) quarterly Return on Capital Employed came in at 1625.37% in Q4 2025, up 171934.0% YoY from N/an in Q4 2024, and down 65.24% on a QoQ basis from 4676.11% in Q3 2025.
AVITA Medical (RCEL) Return on Capital Employed (2020 - 2026) Analysis & Trends
AVITA Medical (RCEL) has 6 years of Return on Capital Employed data on file, last reported at 1625.37% in Q4 2025.
- Quarterly Return on Capital Employed rose 171934.0% year-over-year to 1625.37% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1625.37% (up 171934.0% YoY) and the FY2025 annual result came in at 791.4%, down 71646.0% from the prior year.
- Return on Capital Employed slipped to 1625.37% in Q4 2025, from 4676.11% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 4676.11% in Q3 2025 to a low of 3760.1% in Q2 2025.
- A 5-year average of 96.36% and a median of 44.73% in 2022 frame the typical range for Return on Capital Employed.
- The widest YoY moves for Return on Capital Employed: up 476365 bps in 2025, down 370120 bps in 2025.
- Tracing RCEL's Return on Capital Employed over 5 years: stood at 33.51% in 2021, then plunged by 41 bps to 47.26% in 2022, then fell by 9 bps to 51.31% in 2023, then sank by 83 bps to 93.97% in 2024, then jumped by 1830 bps to 1625.37% in 2025.
- The last three Return on Capital Employed figures came in at 1625.37% (Q4 2025), 4676.11% (Q3 2025), and 3760.1% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | AVITA Medical | 310.57 Mn | 299.44 Mn | 17.77 Mn | 225.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225.89% |
| Dec 31, 2025 | 1,625.37% |
| Sep 30, 2025 | 4,676.11% |
| Jun 30, 2025 | -3,760.10% |
| Mar 31, 2025 | -99.10% |
| Dec 31, 2024 | -93.97% |
| Sep 30, 2024 | -87.54% |
| Jun 30, 2024 | -58.90% |
| Mar 31, 2024 | -47.89% |
| Dec 31, 2023 | -51.31% |
| Sep 30, 2023 | -56.07% |
| Jun 30, 2023 | -41.15% |
| Mar 31, 2023 | -41.74% |
| Dec 31, 2022 | -47.26% |
| Sep 30, 2022 | -42.21% |
| Mar 31, 2022 | -40.87% |
| Sep 30, 2021 | -33.51% |
| Jun 30, 2021 | -27.24% |
| Mar 31, 2021 | -38.04% |
| Dec 31, 2020 | -68.65% |